Table 1 Datasets used in this study.
From: A cross-cohort computational framework to trace tumor tissue-of-origin based on RNA sequencing
Abbreviation | TCGA primary | TCGA metastatic | ICGC | Cancer name |
|---|---|---|---|---|
ACC | 79 | 0 | 0 | Adrenocortical carcinoma |
BLCA | 414 | 0 | 0 | Bladder urothelial carcinoma |
BRCA | 1102 | 7 | 50 | Breast invasive carcinoma |
CESC | 304 | 2 | 0 | Cervical squamous cell carcinoma and endocervical adenocarcinoma |
CHOL | 36 | 0 | 0 | Cholangiocarcinoma |
COAD | 478 | 1 | 0 | Colon adenocarcinoma |
DLBC | 48 | 0 | 107 | Lymphoid neoplasm diffuse large B-cell lymphoma |
ESCA | 161 | 1 | 0 | Esophageal carcinoma |
GBM | 156 | 0 | 0 | Glioblastoma multiforme |
HNSC | 500 | 2 | 40 | Head and neck squamous cell carcinoma |
KICH | 65 | 0 | 0 | Kidney chromophobe |
KIRC | 538 | 0 | 136 | Kidney renal clear cell carcinoma |
KIRP | 288 | 0 | 0 | Kidney renal papillary cell carcinoma |
LAML | 151 | 0 | 323 | Acute myeloid leukemia |
LGG | 511 | 0 | 0 | Brain lower grade glioma |
LIHC | 371 | 0 | 606 | Liver hepatocellular carcinoma |
LUAD | 533 | 0 | 0 | Lung adenocarcinoma |
LUSC | 502 | 0 | 0 | Lung squamous cell carcinoma |
MESO | 86 | 0 | 0 | Mesothelioma |
OV | 374 | 0 | 111 | Ovarian serous cystadenocarcinoma |
PAAD | 177 | 1 | 389 | Pancreatic adenocarcinoma |
PCPG | 178 | 2 | 0 | Pheochromocytoma and paraganglioma |
PRAD | 498 | 1 | 169 | Prostate adenocarcinoma |
READ | 166 | 0 | 0 | Rectum adenocarcinoma |
SARC | 259 | 1 | 57 | Sarcoma |
SKCM | 103 | 367 | 0 | Skin cutaneous melanoma |
STAD | 375 | 0 | 0 | Stomach adenocarcinoma |
TGCT | 150 | 0 | 0 | Testicular germ cell tumors |
THCA | 502 | 8 | 0 | Thyroid carcinoma |
THYM | 119 | 0 | 0 | Thymoma |
UCEC | 551 | 0 | 0 | Uterine corpus endometrial carcinoma |
UCS | 56 | 0 | 0 | Uterine carcinosarcoma |
UVM | 80 | 0 | 0 | Uveal melanoma |
Sum | 9911 | 393 | 1988 | Sum of all cancers |
